About Us
HTDS Medical has found the best way to increase shareholder value, separate and apart from the operating performance of operating subsidiaries, by spinning off and distributing shares of its wholly owned subsidiaries in the form of a special dividend to the Company’s shareholders.
The common stock distributions are part of a broader strategy relating to the transition of HTDS Medical into a company focused on the development and licensing of proprietary technologies.
Company News
-
Possible amalgamation
-
Hard to Treat Diseases, Inc. (HTDS) Reports from Mina Mar's 2nd Annual Shareholder’s Conference
-
Positive influence of hyperbaric oxygenation on recovery from brain trauma
-
Hard to Treat Diseases (HTDS) Plans a Share Buyback Program - March 29, 2010
-
RD expenditures 2009
-
Hard to Treat Diseases (HTDS) Resolves Its Short Position with Scottrade - Shenzen, China, March 11, 2010 - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) announces that Scottrade lifted trading restriction on the HTDS security. Scottrade, the American discount retail brokerage firm, removed the restriction of online trading and buys of HTDS security, as HTDS successfully resolved the issue regarding the company's short position. The company sees this a right move from the brokerage firm and will work diligently to achieve and lift all similar restrictions with brokerages that filed HTDS in their bad books.
-
Chile Buys 2 Million Doses of Swine-Flu Vaccine SANTIAGO – The Chilean government has purchased 2 million doses of the vaccine against the AH1N1 flu virus for the immunization campaign that begins in the second half of March, the Health Ministry said.
Read Full Report Here